OncoGenex Pharmaceuticals (OGXI +7.6%) falls 12.3% AH after filing for a stock offering...

|About: OncoGenex Pharmaceuticals Inc. (OGXI)|By:, SA News Editor

OncoGenex Pharmaceuticals (OGXI +7.6%) falls 12.3% AH after filing for a stock offering featuring an undisclosed number of shares. The company plans to partly use the proceeds to develop its OGX-427 cancer drug, and possibly other drug candidates.